Heron Therapeutics, Inc. Closes Underwritten Offering of Common Stock – MarketWatch

Heron Therapeutics, Inc. Closes Underwritten Offering of Common Stock
MarketWatch
As a component of the offering, in lieu of common stock, Heron Therapeutics, Inc. also offered and sold to certain existing large investors pre-funded warrants to purchase up to an aggregate of 600,000 shares of common stock at a purchase price of $11

and more

…read more

About The Author

Scroll to Top